1. Home
  2. FULC vs ZYBT Comparison

FULC vs ZYBT Comparison

Compare FULC & ZYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • ZYBT
  • Stock Information
  • Founded
  • FULC 2015
  • ZYBT 2004
  • Country
  • FULC United States
  • ZYBT China
  • Employees
  • FULC N/A
  • ZYBT N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • ZYBT
  • Sector
  • FULC Health Care
  • ZYBT
  • Exchange
  • FULC Nasdaq
  • ZYBT NYSE
  • Market Cap
  • FULC 210.9M
  • ZYBT 201.4M
  • IPO Year
  • FULC 2019
  • ZYBT 2025
  • Fundamental
  • Price
  • FULC $3.85
  • ZYBT $4.62
  • Analyst Decision
  • FULC Hold
  • ZYBT
  • Analyst Count
  • FULC 9
  • ZYBT 0
  • Target Price
  • FULC $7.63
  • ZYBT N/A
  • AVG Volume (30 Days)
  • FULC 368.1K
  • ZYBT 33.8K
  • Earning Date
  • FULC 02-25-2025
  • ZYBT 01-01-0001
  • Dividend Yield
  • FULC N/A
  • ZYBT N/A
  • EPS Growth
  • FULC N/A
  • ZYBT N/A
  • EPS
  • FULC N/A
  • ZYBT 0.06
  • Revenue
  • FULC $80,871,000.00
  • ZYBT $26,111,272.00
  • Revenue This Year
  • FULC $2,823.78
  • ZYBT N/A
  • Revenue Next Year
  • FULC N/A
  • ZYBT N/A
  • P/E Ratio
  • FULC N/A
  • ZYBT $75.57
  • Revenue Growth
  • FULC 2987.86
  • ZYBT N/A
  • 52 Week Low
  • FULC $2.86
  • ZYBT $3.70
  • 52 Week High
  • FULC $13.70
  • ZYBT $6.10
  • Technical
  • Relative Strength Index (RSI)
  • FULC 47.75
  • ZYBT N/A
  • Support Level
  • FULC $3.64
  • ZYBT N/A
  • Resistance Level
  • FULC $3.94
  • ZYBT N/A
  • Average True Range (ATR)
  • FULC 0.18
  • ZYBT 0.00
  • MACD
  • FULC 0.02
  • ZYBT 0.00
  • Stochastic Oscillator
  • FULC 84.21
  • ZYBT 0.00

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About ZYBT ZHENGYE BIOTECHNOLOGY HLDG LTD

Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt.

Share on Social Networks: